Nuclear protein in testis midline carcinoma in a Turkish boy: a case report

[1]Schwartz BE, Hofer MD, Lemieux ME, Bauer DE, Cameron MJ, West NH, et al. Differentiation of NUT midline carcinoma by epigenomic reprogramming. Cancer Res. 2011; 71:2686–96.SchwartzBEHoferMDLemieuxMEBauerDECameronMJWestNHDifferentiation of NUT midline carcinoma by epigenomic reprogrammingCancer Res20117126869610.1158/0008-5472.CAN-10-3513307080521447744Search in Google Scholar

[2]French CA, Ramirez CL, Kolmakova J, Hickman TT, Cameron MJ, Thyne ME, et al. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 2008; 27:2237–42.FrenchCARamirezCLKolmakovaJHickmanTTCameronMJThyneMEBRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cellsOncogene20082722374210.1038/sj.onc.121085217934517Search in Google Scholar

[3]French CA. Pathogenesis of NUT midline carcinoma. Ann Rev Pathol. 2012; 7:247–65.FrenchCAPathogenesis of NUT midline carcinomaAnn Rev Pathol201272476510.1146/annurev-pathol-011811-13243822017582Search in Google Scholar

[4]Agaimy A, Fonseca I, Martins C, Thway K, Barrette R, Harrington KJ, et al. NUT Carcinoma of the salivary glands: clinicopathologic and molecular analysis of 3 cases and a survey of NUT expression in salivary gland carcinomas. Am J Surg Pathol. 2018; 42:877–84.AgaimyAFonsecaIMartinsCThwayKBarretteRHarringtonKJNUT Carcinoma of the salivary glands: clinicopathologic and molecular analysis of 3 cases and a survey of NUT expression in salivary gland carcinomasAm J Surg Pathol2018428778410.1097/PAS.0000000000001046601017629649019Search in Google Scholar

[5]Kees UR, Mulcahy MT, Willoughby ML. Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19). Am J Pediatr Hematol Oncol. 1991; 13:459–64.KeesURMulcahyMTWilloughbyMLIntrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19)Am J Pediatr Hematol Oncol1991134596410.1097/00043426-199124000-000111785673Search in Google Scholar

[6]Kubonishi I, Takehara N, Iwata J, Sonobe H, Ohtsuki Y, Abe T, Miyoshi I. Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma. Cancer Res. 1991; 51:3327–8.KubonishiITakeharaNIwataJSonobeHOhtsukiYAbeTMiyoshiINovel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinomaCancer Res19915133278Search in Google Scholar

[7]Stelow EB, Bellizzi AM, Taneja K, Mills SE, Legallo RD, Kutok JL, et al. NUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tract. Am J Surg Pathol. 2008; 32:828–34.StelowEBBellizziAMTanejaKMillsSELegalloRDKutokJLNUT rearrangement in undifferentiated carcinomas of the upper aerodigestive tractAm J Surg Pathol2008328283410.1097/PAS.0b013e31815a390018391746Search in Google Scholar

[8]Bauer DE, Mitchell CM, Strait KM, Lathan CS, Stelow EB, Lüer SC, et al. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res. 2012; 18:5773–9.BauerDEMitchellCMStraitKMLathanCSStelowEBLüerSCClinicopathologic features and long-term outcomes of NUT midline carcinomaClin Cancer Res2012185773910.1158/1078-0432.CCR-12-1153347316222896655Search in Google Scholar

[9]Chirieac LR, French CA, Sholl L, Yatabi Y. Lung: other and unclassified carcinomas. In: Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG, editors. WHO Classification of tumours of the lung, pleura, thymus and heart. 4th ed. Lyon: IARC Press; 2015. p. 97–8.ChirieacLRFrenchCAShollLYatabiYLung: other and unclassified carcinomasIn:TravisWDBrambillaEBurkeAPMarxANicholsonAGeditors.WHO Classification of tumours of the lung, pleura, thymus and heart4th edLyonIARC Press2015978Search in Google Scholar

[10]Boleto G, Perotin JM, Launois C, Uro-Coste E, Birembaut P, Dury S, et al. Nuclear protein in testis carcinoma of the mediastinum: a case report. J Med Case Rep. 2017; 11:152. doi: 10.1186/s13256-017-1328-xBoletoGPerotinJMLaunoisCUro-CosteEBirembautPDurySNuclear protein in testis carcinoma of the mediastinum: a case reportJ Med Case Rep.20171115210.1186/s13256-017-1328-x546552628595655Open DOISearch in Google Scholar

[11]Haack H, Johnson LA, Fry CJ, Crosby K, Polakiewicz RD, Stelow EB, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009; 33:984–91.HaackHJohnsonLAFryCJCrosbyKPolakiewiczRDStelowEBDiagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibodyAm J Surg Pathol2009339849110.1097/PAS.0b013e318198d666278340219363441Search in Google Scholar

[12]Wang H, Weiss VL, Hoffman RD, Abel T, Ho RH, Borinstein SC, et al. Salivary gland NUT carcinoma with prolonged survival in children: case illustration and systematic review of literature. Head Neck Pathol. 2020. doi: 10.1007/s12105-020-01141-3WangHWeissVLHoffmanRDAbelTHoRHBorinsteinSCSalivary gland NUT carcinoma with prolonged survival in children: case illustration and systematic review of literatureHead Neck Pathol202010.1007/s12105-020-01141-3801004032077054Open DOISearch in Google Scholar

[13]Prasad M, Baheti A, Ramadwar M, Chinnaswamy G, Vora T, Qureshi S. Pediatric NUT carcinoma is a rare and challenging tumor: single center experience of five children. Oncologist. 2019; 24:e1232–5.PrasadMBahetiARamadwarMChinnaswamyGVoraTQureshiSPediatric NUT carcinoma is a rare and challenging tumor: single center experience of five childrenOncologist201924e1232510.1634/theoncologist.2019-0358685309431488618Search in Google Scholar

[14]Lemelle L, Pierron G, Fréneaux P, Sophie Huybrechts S, Spiegel A, Plantaz D, et al. NUT carcinoma in children and adults: a multicenter retrospective study. Pediatr Blood Cancer. 2017; 64:e26693. doi: 10.1002/pbc.26693LemelleLPierronGFréneauxPSophie HuybrechtsSSpiegelAPlantazDNUT carcinoma in children and adults: a multicenter retrospective studyPediatr Blood Cancer201764e2669310.1002/pbc.2669328643357Open DOISearch in Google Scholar

[15]Zhou L, Yong X, Zhou J, Xu J, Wang C. Clinicopathological analysis of five cases of NUT midline carcinoma, including one with the gingiva. Biomed Res Int. 2020; 2020:9791208. doi: 10.1155/2020/9791208.ZhouLYongXZhouJXuJWangCClinicopathological analysis of five cases of NUT midline carcinoma, including one with the gingivaBiomed Res Int20202020979120810.1155/2020/9791208704250532149149Open DOISearch in Google Scholar

[16]Chau NG, Hurwitz S, Mitchell CM, Aserlind A, Grunfeld N, Kaplan L, et al. Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck. Cancer. 2016; 122:3632–40.ChauNGHurwitzSMitchellCMAserlindAGrunfeldNKaplanLIntensive treatment and survival outcomes in NUT midline carcinoma of the head and neckCancer201612236324010.1002/cncr.30242536161427509377Search in Google Scholar

[17]Sopfe J, Greffe B, Treece AL. Metastatic NUT midline carcinoma treated with aggressive neoadjuvant chemotherapy, radiation, and resection: a case report and review of the literature. J Pediatr Hematol Oncol. 2020. doi: 10.1097/MPH.0000000000001860SopfeJGreffeBTreeceALMetastatic NUT midline carcinoma treated with aggressive neoadjuvant chemotherapy, radiation, and resection: a case report and review of the literatureJ Pediatr Hematol Oncol202010.1097/MPH.000000000000186032555032Open DOISearch in Google Scholar